Herd Immunity and Population Protection

Herd Immunity: Core Concept - Shielding the Masses

• Definition: Indirect protection from infectious disease when a high proportion of a population is immune, reducing transmission. Also known as community immunity.
• Mechanism: Immune individuals form a barrier, ↓ probability of infection spread to susceptible persons. The chain of transmission is disrupted.
• Primary Goal: Protects vulnerable individuals who cannot be vaccinated effectively.
  • E.g., neonates, immunocompromised patients, individuals with vaccine contraindications.

⭐ Herd immunity protects unvaccinated individuals, including those ineligible for vaccines (e.g., newborns, immunocompromised).

Herd Immunity Threshold (HIT) - The Numbers Game

• HIT: Min. proportion of immune population to halt disease spread, protecting unvaccinated individuals.
• Determined by Basic Reproduction Number ($R_0$).
  • $R_0$: Average secondary infections from one case in a fully susceptible population.
• Formula: HIT = $1 - 1/R_0$.
  • Higher $R_0$ (e.g., Measles $R_0$ 12-18) means higher HIT needed (approx. 83-94%).
• Adjusting for Vaccine Efficacy (VE):
  • If vaccine efficacy (VE) < 100%, required Pc = $HIT / VE$.
  • E.g.: For HIT 85% & VE 90%, Pc $\approx$ 94.4% (calculated as $0.85/0.90$).

⭐ The basic reproduction number (R₀) is a key determinant of the herd immunity threshold; higher R₀ necessitates greater population immunity. The formula is HIT = 1 - 1/R₀.

Achieving Herd Immunity - Vax Power Up!

• Concept: Indirect protection of unvaccinated; high population immunity ↓ pathogen circulation.

• Key Metric: Herd Immunity Threshold (HIT). Formula: $1 - 1/R_0$.

  • $R_0$ (Basic Reproduction Number): Higher $R_0$ requires higher HIT.

• Achieved via: Sustained mass vaccination.

• Factors: Pathogen $R_0$, vaccine efficacy (E), coverage, immunity duration, population mixing.

⭐ For vaccines not 100% effective, the proportion of population to be vaccinated (Pc) to achieve herd immunity is Pc = (1 - 1/R₀) / E, where E is vaccine efficacy.

• Benefits: Protects vulnerable (immunocompromised, infants, elderly).
• Challenges: Vaccine hesitancy, waning immunity, antigenic variation (e.g., influenza).

Impact & Challenges - Herd Power & Hurdles

• Herd Power (Impact):
  • Shields vulnerable individuals: newborns, elderly, immunocompromised.
  • Drastically ↓ pathogen circulation, breaking transmission chains.
  • Aims for disease elimination (e.g., measles) or eradication (e.g., polio).
  • Substantial public health & economic benefits.
• Hurdles (Challenges):
  • High, sustained vaccination coverage essential (Herd Immunity Threshold: $H_{IT} = 1 - 1/R_0$).
  • Vaccine hesitancy, misinformation, and logistical gaps in delivery.
  • Immunity decline over time (waning immunity), necessitating boosters.
  • Primary vaccine failure & less than 100% vaccine efficacy.
  • Pathogen evolution (e.g., antigenic drift/shift) impacting vaccine effectiveness.

⭐ Failure to achieve or maintain herd immunity due to factors like vaccine hesitancy or waning immunity can lead to resurgence of vaccine-preventable diseases.

High‑Yield Points - ⚡ Biggest Takeaways

• Herd immunity provides indirect protection to unvaccinated individuals.
• Achieved when a critical proportion (Herd Immunity Threshold, HIT) becomes immune.
• HIT is calculated as (1 - 1/R0) x 100%, linked to the Basic Reproduction Number (R0).
• Essential for safeguarding vulnerable groups (e.g., immunocompromised, infants).
• High vaccine coverage and efficacy are prerequisites.
• Does not apply to non-communicable infections like tetanus.
• Factors like waning immunity or new pathogen variants can impact its effectiveness.